Literature DB >> 9715445

Trochanteric flip osteotomy for cranial extension and muscle protection in acetabular fracture fixation using a Kocher-Langenbeck approach.

K A Siebenrock1, E Gautier, B H Ziran, R Ganz.   

Abstract

OBJECTIVE: To describe the advantages and surgical technique of a trochanteric flip osteotomy in combination with a Kocher-Langenbeck approach for the treatment of selected acetabular fractures.
DESIGN: Consecutive series, teaching hospital.
METHODS: Through mobilization of the vastus lateralis muscle, a slice of the greater trochanter with the attached gluteus medius muscle can be flipped anteriorly. The gluteus minimus muscle can then be easily mobilized, giving free access to the posterosuperior and superior acetabular wall area. Damage to the abductor muscles by vigorous retraction can be avoided, potentially resulting in less ectopic ossification. Ten consecutive cases of acetabular fractures treated with this approach are reported. In eight cases, an anatomic reduction was achieved; in the remaining two cases with severe comminution, the reduction was within one to three millimeters. The trochanteric fragment was fixed with two 3.5-millimeter cortical screws.
RESULTS: All osteotomies healed in anatomic position within six to eight weeks postoperatively. Abductor strength was symmetric in eight patients and mildly reduced in two patients. Heterotopic ossification was limited to Brooker classes 1 and 2 without functional impairment at an average follow-up of twenty months. No femoral head necrosis was observed.
CONCLUSION: This technique allows better visualization, more accurate reduction, and easier fixation of cranial acetabular fragments. Cranial migration of the greater trochanter after fixation with two screws is unlikely to occur because of the distal pull of the vastus lateralis muscle, balancing the cranial pull of the gluteus medius muscle.

Entities:  

Mesh:

Year:  1998        PMID: 9715445     DOI: 10.1097/00005131-199808000-00004

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  20 in total

1.  The modified Gibson approach to the acetabulum.

Authors:  B R Moed
Journal:  Oper Orthop Traumatol       Date:  2014-11-15       Impact factor: 1.154

2.  Treatment of posttraumatic labral interposition with surgical hip dislocation and labral repair.

Authors:  Jeffrey J Nepple; Perry L Schoenecker; John C Clohisy
Journal:  Iowa Orthop J       Date:  2011

3.  Use of a trochanteric flip osteotomy improves outcomes in Pipkin IV fractures.

Authors:  Brian D Solberg; Charles N Moon; Dennis P Franco
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

4.  Should trochanteric osteotomy be always avoided during safe hip dislocation?

Authors:  Alessandro Aprato; Chiara Baroni; Alessandro Massè
Journal:  Ann Transl Med       Date:  2016-10

5.  [Osteotomy of the greater trochanter].

Authors:  K Anagnostakos; D Kohn; O Lorbach
Journal:  Orthopade       Date:  2013-05       Impact factor: 1.087

6.  Surgical dislocation technique for the treatment of acetabular fractures.

Authors:  Alessandro Masse; Alessandro Aprato; Luca Rollero; Andrea Bersano; Reinhold Ganz
Journal:  Clin Orthop Relat Res       Date:  2013-09-04       Impact factor: 4.176

Review 7.  [Operative treatment of T-type fractures of the acetabulum via surgical hip dislocation or Stoppa approach].

Authors:  Moritz Tannast; Klaus-Arno Siebenrock
Journal:  Oper Orthop Traumatol       Date:  2009-09       Impact factor: 1.154

Review 8.  Articular disimpaction in acetabular fractures.

Authors:  Srinivas Kasha; Ranjith Kumar Yalamanchili
Journal:  J Clin Orthop Trauma       Date:  2020-09-18

9.  [Posterior approaches to the acetabulum].

Authors:  K-A Siebenrock; M Tannast; J D Bastian; M J B Keel
Journal:  Unfallchirurg       Date:  2013-03       Impact factor: 1.000

10.  [Current therapy options for fractures of the femoral head].

Authors:  A Thannheimer; P Gutsfeld; V Bühren
Journal:  Chirurg       Date:  2009-12       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.